Progyny Reports Strong Q1 2026 Earnings with 61% Net Income Growth and Completes $200M Share Buyback
PGNY sits 36% above its 52-week low of $16.1.
Summary
Progyny reported strong Q1 2026 results, including a 61% increase in net income and a 70.6% rise in diluted EPS, alongside the completion of its $200 million share repurchase program.
Key Events · Earnings and Guidance · PGNY
-
Strong Q1 2026 Financial Performance
Progyny reported net income of $24.2 million, a 61% increase from Q1 2025, and diluted EPS of $0.29, up 70.6%. Gross profit grew 10% to $83.1 million, with gross margin expanding by 190 basis points to 25.3%.
-
Completion of $200M Share Repurchase Program
The company completed its previously authorized $200 million share repurchase program, buying back 5,511,824 shares for $116.6 million in Q1 2026 at an average price of $21.13 per share.
-
Client and Member Base Expansion
Progyny expanded its client base to 595 (from 555 at year-end 2025) and its member base to 7.179 million (from 6.689 million), despite a modest 1% revenue increase attributed to the non-renewal of a large client in 2025.
-
CEO Terminates 10b5-1 Selling Plan
CEO Peter Anevski terminated a Rule 10b5-1 trading plan on January 26, 2026, which had provided for the sale of up to 1,244,220 shares.
Analysis · PGNY · Industrial Applications And Services
Progyny, Inc. filed its Q1 2026 earnings report, detailing robust financial performance with significant net income and EPS growth. The company successfully completed its $200 million share repurchase program, executing $116.6 million of repurchases in the first quarter alone. While revenue growth was modest at 1%, this was attributed to the previously disclosed non-renewal of a large client in 2025. The company demonstrated continued expansion in its client and member base. Additionally, the CEO's termination of a 10b5-1 selling plan removes a potential overhang, signaling a neutral to slightly positive sentiment regarding future insider selling.
How filings like this one have moved
In the 30 days to Aug 24, 2026, 29.4% of the 2796 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.03%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PGNY was trading at $21.87 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $16.10 to $28.75. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.